https://m2.mtmt.hu/ hun 2026-09-22 07:54 JournalArticle 35733167 ADMIN_APPROVED true 0 false 2026-08-13T07:08:51.663+0000 2026-06-02T09:09:50.881+0000 2025-02-03T11:00:34.179+0000 true 10093816 Peresztegi Krisztina /api/admin/10093816 Admin Peresztegi Krisztina (admin) false 2026-08-03T12:55:59.625+0000 2026-06-02T09:09:51.356+0000 true 10003133 Boros Annamária /api/admin/10003133 Admin Boros Annamária (MTMT Központi admin) true 10003133 Admin 10003133 /api/admin/10003133 Boros Annamária (MTMT Központi admin) Boros Annamária true 10003133 true 2026-06-05T13:23:20.831+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Balázs, Péter György true true /api/journal/487 REVIEWED ARCHIVES OF DERMATOLOGICAL RESEARCH 0340-3696 1432-069X true false 487 false 487 true 0340-3696 1432-069X Journal FOREIGN 317 1 291 291 14 2025 This study aims to explore the measurement agreement between direct and indirect health utility measures in four chronic dermatological conditions (atopic dermatitis, hidradenitis suppurativa, pemphigus, psoriasis). Outpatients survey data collected between 2015 and 2021 were analysed. Health-related quality of life (HRQoL) outcome measures included time trade-off (TTO), EQ-5D-5L and Dermatology Life Quality Index (DLQI). Descriptive statistics were computed for the pooled sample and four diseases. Mean, standard deviation (SD), median, interquartile range (IQR), ceiling and floor effects were calculated for TTO, EQ-5D-5L and DLQI utilities. Bland‒Altman plots and intraclass correlation coefficients (ICC) were applied to investigate the agreement between health utility measures. Sociodemographic characteristics (age, sex, educational level, employment status) and health-related information (disease duration, outpatient care visits in the past 3 months and disease severity) impact on utilities was investigated by Tobit regressions. The sample includes N = 765 patient responses with a mean age of 41.5 (SD = 16.2), majority being males (52.7%). Total sample mean utilities were the highest according to TTO (0.83), followed by EQ-5D-5L and vDLQI (0.81 and 0.81) and lowest in mDLQI (0.77). Measurement agreement was found only between TTO and EQ-5D-5L. Skin-disease severity impacted all health state utilities, though only TTO differentiated utility values according to disease type. The discrepancies between the TTO and DLQI warn to compare DLQI-based utilities in different dermatological conditions with extreme caution. true true 2025 true true true false true false GREEN 2026-08-13 true http://unipub.lib.uni-corvinus.hu/10885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 19 Q1 false false false false 2025-02-05T12:37:07.505+0000 Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K); Bőrgyógyászati Tanszék (DE / ÁOK); Egészségpolitika Tanszék (BCE / TPTI) 11 38 3 12 0 true 10003133 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 123082205 /api/authorship/123082205 Balázs, Péter György ✉ [Balázs, Péter György (Egészség-gazdaságtan), szerző] Egészségpolitika Tanszék (BCE / TPTI) 1 0.083 true false true Author 10070945 /api/author/10070945 Balázs Péter György (Egészség-gazdaságtan) Balázs Péter György true true Balázs Péter György true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082206 /api/authorship/123082206 Gáspár, Krisztián [Gáspár, Krisztián (Bőrgyógyászat, al...), szerző] Bőrgyógyászati Tanszék (DE / ÁOK) 2 0.083333336 false false false Author 10043775 /api/author/10043775 Gáspár Krisztián (Bőrgyógyászat, allergológia, immunológia) Gáspár Krisztián true 10043775 true Gáspár Krisztián true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082207 /api/authorship/123082207 Gergely, Hunor L. [Gergely, László Hunor (Bőr- és nemi bete...), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 3 0.083 false false false Author 10069064 /api/author/10069064 Gergely László Hunor (Bőr- és nemi betegségek) Gergely László Hunor true true Gergely Hunor L. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082208 /api/authorship/123082208 Hajdú, Krisztina 4 0.083333336 false false false Hajdú Krisztina true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082209 /api/authorship/123082209 Holló, Péter [Holló, Péter (Bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 5 0.083 false false false Author 10019467 /api/author/10019467 Holló Péter (Bőrgyógyászat) Holló Péter true 10019467 true Holló Péter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082210 /api/authorship/123082210 Koszorú, Kamilla [Koszorú, Kamilla (Bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 6 0.083 false false false Author 10070359 /api/author/10070359 Koszorú Kamilla (Bőrgyógyászat) Koszorú Kamilla true true Koszorú Kamilla true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082211 /api/authorship/123082211 Poór, Adrienn Katalin [Poór, Adrienn Katalin (bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 7 0.083 false false false Author 10037620 /api/author/10037620 Poór Adrienn Katalin (bőrgyógyászat) Poór Adrienn Katalin true 10037620 true Poór Adrienn Katalin true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082212 /api/authorship/123082212 Sárdy, Miklós [Sárdy, Miklós (Bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 8 0.083 false false false Author 10015457 /api/author/10015457 Sárdy Miklós (Bőrgyógyászat) Sárdy Miklós true 10015457 true Sárdy Miklós true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082213 /api/authorship/123082213 Szegedi, Andrea [Szegedi, Andrea (Dermatológia - im...), szerző] Bőrgyógyászati Tanszék (DE / ÁOK) 9 0.083 false false false Author 10010393 /api/author/10010393 Szegedi Andrea (Dermatológia - immunológia) Szegedi Andrea true 10010393 true Szegedi Andrea true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082214 /api/authorship/123082214 Tamási, Béla [Tamási, Béla (bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 10 0.083 false false false Author 10037581 /api/author/10037581 Tamási Béla (bőrgyógyászat) Tamási Béla true 10037581 true Tamási Béla true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082215 /api/authorship/123082215 Wikonkál, Norbert [Wikonkál, Norbert (Bőrgyógyászat), szerző] Bőr-, Nemikórtani és Bőronkológiai Klinika (SE / AOK / K) 11 0.083 false false false Author 10002438 /api/author/10002438 Wikonkál Norbert (Bőrgyógyászat) Wikonkál Norbert true 10002438 true Wikonkál Norbert true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123082216 /api/authorship/123082216 Brodszky, Valentin [Brodszky, Valentin (health outcome re...), szerző] Egészségpolitika Tanszék (BCE / TPTI) 12 0.083 false true false Author 10020545 /api/author/10020545 Brodszky Valentin (health outcome research) Brodszky Valentin true 10020545 true Brodszky Valentin true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 28332219 /api/publicationidentifier/28332219 DOI: 10.1007/s00403-024-03786-4 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1007/s00403-024-03786-4 https://doi.org/10.1007/s00403-024-03786-4 false true PublicationIdentifier 28332220 /api/publicationidentifier/28332220 WoS: 001400510600008 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001400510600008 https://www.webofscience.com/wos/woscc/full-record/001400510600008 false true PublicationIdentifier 28348595 /api/publicationidentifier/28348595 CorvinusKutatasok: 10885 SwordSource 94 /api/publicationsource/94 CorvinusKutatasok PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true CorvinusKutatasok http://unipub.lib.uni-corvinus.hu/@@@ true true 94 true GREEN true IDENTICAL 10885 http://unipub.lib.uni-corvinus.hu/10885 false true PublicationIdentifier 28356747 /api/publicationidentifier/28356747 Scopus: 85216254902 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85216254902 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85216254902 false true PublicationIdentifier 28356748 /api/publicationidentifier/28356748 PubMed: 39825944 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39825944 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39825944&dopt=Abstract false true Classification 12279 /api/classification/12279 Bőrgyógyászat és nemibeteg-gondozás true true Classification 12124 /api/classification/12124 Orvos- és egészségtudomány true true SjrRating 11572528 /api/sjrrating/11572528 sjr:Q1 (2025) Scopus - Dermatology ARCHIVES OF DERMATOLOGICAL RESEARCH 0340-3696 1432-069X 33 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2708 /api/classificationexternal/2708 Scopus - Dermatology true 2708 true Q1 DIRECT true true Reference 62854935 /api/reference/62854935 1. Chernyshov PV (2019) The evolution of quality of life assessment and use in dermatology. Dermatology. https://doi.org/10.1159/000496923, DOI: 10.1159/000496923 1 10.1159/000496923 false true Reference 62854936 /api/reference/62854936 2. Christensen RE, Jafferany M (2023) Psychiatric and psychologic aspects of chronic skin diseases. Clin Dermatol. https://doi.org/10.1016/j.clindermatol.2023.03.006, DOI: 10.1016/j.clindermatol.2023.03.006 2 10.1016/j.clindermatol.2023.03.006 false true Reference 62854937 /api/reference/62854937 3. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, McCall CO, Goldstein MK (2004) A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. https://doi.org/10.1046/j.1087-0024.2003.09112.x, DOI: 10.1046/j.1087-0024.2003.09112.x 3 10.1046/j.1087-0024.2003.09112.x false true Reference 62854938 /api/reference/62854938 4. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY (2008) The dermatology life quality index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. https://doi.org/10.1111/j.1365-2133.2008.08832.x, DOI: 10.1111/j.1365-2133.2008.08832.x 4 10.1111/j.1365-2133.2008.08832.x false true Reference 62854939 /api/reference/62854939 5. Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M, Puig L, Stratigos A (2022) Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.18050, DOI: 10.1111/jdv.18050 5 10.1111/jdv.18050 false true Reference 62854940 /api/reference/62854940 6. Song HJ, Park H, Park SY, Lee EK, Ha SY, Park SY, Bae EJ, Ku H (2019) Estimation of health utilities based on the response to treatment in atopic dermatitis: a population-based study. Clin Ther. https://doi.org/10.1016/j.clinthera.2019.02.007, DOI: 10.1016/j.clinthera.2019.02.007 6 10.1016/j.clinthera.2019.02.007 false true Reference 62854941 /api/reference/62854941 7. Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å (2020) Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. https://doi.org/10.2340/00015555-3510, DOI: 10.2340/00015555-3510 7 10.2340/00015555-3510 false true Reference 62854942 /api/reference/62854942 8. Gergely LH, Gáspár K, Brodszky V, Kinyó Á, Szegedi A, Remenyik É, Kiss NF, Bató A, Péntek M, Gulácsi L, Sárdy M, Bánvölgyi A, Wikonkál N, Rencz F (2020) Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.16642, DOI: 10.1111/jdv.16642 8 10.1111/jdv.16642 false true Reference 62854943 /api/reference/62854943 9. Liu L, Li S, Zhao Y, Zhang J, Chen G (2018) Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China. Qual Life Res. https://doi.org/10.1007/s11136-018-1819-2, DOI: 10.1007/s11136-018-1819-2 9 10.1007/s11136-018-1819-2 false true Reference 62854944 /api/reference/62854944 10. Rencz F, Gulácsi L, Péntek M, Szegedi A, Remenyik É, Bata-Csörgő Z, Bali G, Hidvégi B, Tamási B, Poór AK, Hajdu K, Holló P, Kinyó Á, Sárdy M, Brodszky V (2020) DLQI-R scoring improves the discriminatory power of the dermatology life quality index in patients with psoriasis, pemphigus and morphea. Br J Dermatol. https://doi.org/10.1111/bjd.18435, DOI: 10.1111/bjd.18435 10 10.1111/bjd.18435 false true Reference 62854945 /api/reference/62854945 11. Rencz F, Brodszky V, Stalmeier PF, Tamási B, Kárpáti S, Péntek M, Baji P, Mitev AZ, Gulácsi L (2016) Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment. Br J Dermatol. https://doi.org/10.1111/bjd.14647, DOI: 10.1111/bjd.14647 11 10.1111/bjd.14647 false true Reference 62854946 /api/reference/62854946 12. Rencz F, Gulácsi L, Drummond M, Golicki D, Prevolnik Rupel V, Simon J, Stolk EA, Brodszky V, Baji P, Závada J (2016) EQ-5D in central and Eastern Europe: 2000–2015. Qual Life Res. https://doi.org/10.1007/s11136-016-1375-6, DOI: 10.1007/s11136-016-1375-6 12 10.1007/s11136-016-1375-6 false true Reference 62854947 /api/reference/62854947 13. Chen CL, Kuppermann M, Caughey AB, Zane LT (2008) A community-based study of acne-related health preferences in adolescents. Arch Dermatol. https://doi.org/10.1001/archderm.144.8.988, DOI: 10.1001/archderm.144.8.988 13 10.1001/archderm.144.8.988 false true Reference 62854948 /api/reference/62854948 14. Yang Z, Li S, Wang X, Chen G (2020) Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis. J Dermatolog Treat. https://doi.org/10.1080/09546634.2020.1800571, DOI: 10.1080/09546634.2020.1800571 14 10.1080/09546634.2020.1800571 false true Reference 62854949 /api/reference/62854949 15. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R (2006) Quality of life in patients with psoriasis. Health Qual Life Outcomes. https://doi.org/10.1186/1477-7525-4-35, DOI: 10.1186/1477-7525-4-35 15 10.1186/1477-7525-4-35 false true Reference 62854950 /api/reference/62854950 16. Marcellusi A, Capone A, Favato G, Mennini FS, Baio G, Haeussler K, Bononi M (2015) Health utilities lost and risk factors associated with HPV-induced diseases in men and women: the HPV Italian collaborative study group. Clin Ther. https://doi.org/10.1016/j.clinthera.2014.11.002, DOI: 10.1016/j.clinthera.2014.11.002 16 10.1016/j.clinthera.2014.11.002 false true Reference 62854951 /api/reference/62854951 17. Meregaglia M, Cairns J (2017) A systematic literature review of health state utility values in head and neck cancer. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-017-0748-z, DOI: 10.1186/s12955-017-0748-z 17 10.1186/s12955-017-0748-z false true Reference 62854952 /api/reference/62854952 18. van Nooten F, Busschbach J, van Agthoven M, van Exel J, Brouwer W (2018) What should we know about the person behind a TTO? Eur J Health Econ. https://doi.org/10.1007/s10198-018-0975-1, DOI: 10.1007/s10198-018-0975-1 18 10.1007/s10198-018-0975-1 false true Reference 62854953 /api/reference/62854953 19. van Nooten FE, van Exel NJA, Koolman X, Brouwer WBF (2015) “Married with children” the influence of significant others in TTO exercises. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-015-0276-7, DOI: 10.1186/s12955-015-0276-7 19 10.1186/s12955-015-0276-7 false true Reference 62854954 /api/reference/62854954 20. van Nooten FE, van Exel NJ, Eriksson D, Brouwer WB (2016) “Back to the future”: Influence of beliefs regarding the future on TTO answers. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-015-0402-6, DOI: 10.1186/s12955-015-0402-6 20 10.1186/s12955-015-0402-6 false true Reference 62854955 /api/reference/62854955 21. Hernández Alava M, Wailoo A, Wolfe F, Michaud K (2013) A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes. Med Decis Making. https://doi.org/10.1177/0272989X13500720, DOI: 10.1177/0272989X13500720 21 10.1177/0272989X13500720 false true Reference 62854956 /api/reference/62854956 22. Torrance GW (1987) Utility approach to measuring health-related quality of life. J Chronic Dis. https://doi.org/10.1016/0021-9681(87)90019-1, DOI: 10.1016/0021-9681(87)90019-1 22 10.1016/0021-9681(87)90019-1 false true Reference 62854957 /api/reference/62854957 23. Kennedy-Martin M, Slaap B, Herdman M, van Reenen M, Kennedy-Martin T, Greiner W, Busschbach J, Boye KS (2020) Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ. https://doi.org/10.1007/s10198-020-01195-8, DOI: 10.1007/s10198-020-01195-8 23 10.1007/s10198-020-01195-8 false true Reference 62854958 /api/reference/62854958 24. Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N (2016) EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. https://doi.org/10.1007/s40273-016-0404-1, DOI: 10.1007/s40273-016-0404-1 24 10.1007/s40273-016-0404-1 false true Reference 62854959 /api/reference/62854959 25. Rencz F, Brodszky V, Gulácsi L, Golicki D, Ruzsa G, Pickard AS, Law EH, Péntek M (2020) Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary. Value Health. https://doi.org/10.1016/j.jval.2020.03.019, DOI: 10.1016/j.jval.2020.03.019 25 10.1016/j.jval.2020.03.019 false true Reference 62854960 /api/reference/62854960 26. Poudel N, Fahim SM, Qian J, Garza K, Chaiyakunapruk N, Ngorsuraches S (2022) Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review. J Med Econ. https://doi.org/10.1080/13696998.2022.2066441, DOI: 10.1080/13696998.2022.2066441 26 10.1080/13696998.2022.2066441 false true Reference 62854961 /api/reference/62854961 27. Yepes-Nuñez JJ, Guyatt GH, Gómez-Escobar LG, Pérez-Herrera LC, Chu AWL, Ceccaci R, Acosta-Madiedo AS, Wen A, Moreno-López S, MacDonald M, Barrios M, Chu X, Islam N, Gao Y, Wong MM, Couban R, Garcia E, Chapman E, Oykhman P, Chen L, Winders T, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin SA, O’Brien M, Ong PY, Silverberg JI, Spergel J, Wang J, Wheeler KE, Schneider L, Chu DK (2023) Allergen immunotherapy for atopic dermatitis: systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2022.09.020, DOI: 10.1016/j.jaci.2022.09.020 27 10.1016/j.jaci.2022.09.020 false true Reference 62854962 /api/reference/62854962 28. Paul C, Gourraud PA, Bronsard V, Prey S, Puzenat E, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP (2010) Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/j.1468-3083.2009.03561.x, DOI: 10.1111/j.1468-3083.2009.03561.x 28 10.1111/j.1468-3083.2009.03561.x false true Reference 62854963 /api/reference/62854963 29. Kimball AB, Kirby J, Ingram JR, Tran T, Pansar I, Ciaravino V, Willems D, Lewis-Mikhael AM, Tongbram V, Garg A (2024) Burden of hidradenitis suppurativa: a systematic literature review of patient reported outcomes. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-023-01085-w, DOI: 10.1007/s13555-023-01085-w 29 10.1007/s13555-023-01085-w false true Reference 62854964 /api/reference/62854964 30. Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K (2018) Generating EQ-5D-3L utility scores from the dermatology life quality index: a mapping study in patients with psoriasis. Value Health. https://doi.org/10.1016/j.jval.2017.10.024, DOI: 10.1016/j.jval.2017.10.024 30 10.1016/j.jval.2017.10.024 false true Reference 62854965 /api/reference/62854965 31. Ruzsa G, Rencz F, Brodszky V (2022) Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-022-01995-x, DOI: 10.1186/s12955-022-01995-x 31 10.1186/s12955-022-01995-x false true Reference 62854966 /api/reference/62854966 32. Ali FM, Kay R, Finlay AY, Piguet V, Kupfer J, Dalgard F, Salek MS (2017) Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression. Qual Life Res. https://doi.org/10.1007/s11136-017-1607-4, DOI: 10.1007/s11136-017-1607-4 32 10.1007/s11136-017-1607-4 false true Reference 62854967 /api/reference/62854967 33. Vilsbøll AW, Kragh N, Hahn-Pedersen J, Jensen CE (2020) Mapping dermatology life quality index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the national health and wellness study. Qual Life Res. https://doi.org/10.1007/s11136-020-02499-1, DOI: 10.1007/s11136-020-02499-1 33 10.1007/s11136-020-02499-1 false true Reference 62854968 /api/reference/62854968 34. Torrance GW, Furlong W, Feeny D, Boyle M (1995) Multi-attribute preference functions. Health utilities index. Pharmacoeconomics. https://doi.org/10.2165/00019053-199507060-00005, DOI: 10.2165/00019053-199507060-00005 34 10.2165/00019053-199507060-00005 false true Reference 62854969 /api/reference/62854969 35. Katanyoo K, Thavorncharoensap M, Chaikledkaew U, Riewpaiboon A (2022) A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer. Expert Rev Pharmacoecon Outcomes Res. https://doi.org/10.1080/14737167.2021.1906224, DOI: 10.1080/14737167.2021.1906224 35 10.1080/14737167.2021.1906224 false true Reference 62854970 /api/reference/62854970 36. Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F (2006) Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Arthritis Rheum. https://doi.org/10.1002/art.22226, DOI: 10.1002/art.22226 36 10.1002/art.22226 false true Reference 62854971 /api/reference/62854971 37. Li S, Wang M, Liu L, Chen G (2019) Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China. Eur J Cancer Care. https://doi.org/10.1111/ecc.12965, DOI: 10.1111/ecc.12965 37 10.1111/ecc.12965 false true Reference 62854972 /api/reference/62854972 38. Spencer A, Tomeny E, Mujica-Mota RE, Robinson A, Covey J, Pinto-Prades JL (2019) Do time trade-off values fully capture attitudes that are relevant to health-related choices? Eur J Health Econ. https://doi.org/10.1007/s10198-018-1017-8, DOI: 10.1007/s10198-018-1017-8 38 10.1007/s10198-018-1017-8 false true Reference 62854973 /api/reference/62854973 39. Pullenayegum EM, Pickard AS, Xie F (2019) Latent class models reveal poor agreement between discrete-choice and time tradeoff preferences. Med Decis Making. https://doi.org/10.1177/0272989x19841592, DOI: 10.1177/0272989x19841592 39 10.1177/0272989x19841592 false true Reference 62854974 /api/reference/62854974 40. Bató A, Brodszky V, Gergely LH, Gáspár K, Wikonkál N, Kinyó Á, Szabó Á, Beretzky Z, Szegedi A, Remenyik É, Kiss N, Sárdy M, Rencz F (2021) The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Qual Life Res. https://doi.org/10.1007/s11136-020-02732-x, DOI: 10.1007/s11136-020-02732-x 40 10.1007/s11136-020-02732-x false true Reference 62854975 /api/reference/62854975 41. Yfantopoulos J, Chantzaras A, Kontodimas S (2017) Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Arch Dermatol Res. https://doi.org/10.1007/s00403-017-1743-2, DOI: 10.1007/s00403-017-1743-2 41 10.1007/s00403-017-1743-2 false true Reference 62854976 /api/reference/62854976 42. Whitehurst DG, Norman R, Brazier JE, Viney R (2014) Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Value Health. https://doi.org/10.1016/j.jval.2014.03.1720, DOI: 10.1016/j.jval.2014.03.1720 42 10.1016/j.jval.2014.03.1720 false true Reference 62854977 /api/reference/62854977 43. Turner N, Campbell J, Peters TJ, Wiles N, Hollinghurst S (2013) A comparison of four different approaches to measuring health utility in depressed patients. Health Qual Life Outcomes. https://doi.org/10.1186/1477-7525-11-81, DOI: 10.1186/1477-7525-11-81 43 10.1186/1477-7525-11-81 false true Reference 62854978 /api/reference/62854978 44. Noel CW, Lee DJ, Kong Q, Xu W, Simpson C, Brown D, Gilbert RW, Gullane PJ, Irish JC, Huang SH, O’Sullivan B, Goldstein DP, de Almeida JR (2015) Comparison of Health State Utility Measures in Patients With Head and Neck Cancer. JAMA Otolaryngology-Head & Neck Surgery. https://doi.org/10.1001/jamaoto.2015.1314, DOI: 10.1001/jamaoto.2015.1314 44 10.1001/jamaoto.2015.1314 false true Reference 62854979 /api/reference/62854979 45. Klassen AF, Newton JN, Mallon E (2000) Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol. https://doi.org/10.1067/mjd.2000.105507, DOI: 10.1067/mjd.2000.105507 45 10.1067/mjd.2000.105507 false true Reference 62854980 /api/reference/62854980 46. Both H, Essink-Bot M-L, Busschbach J, Nijsten T (2007) Critical review of generic and dermatology-specific health-related quality of life instruments. J Investig Dermatol. https://doi.org/10.1038/sj.jid.5701142, DOI: 10.1038/sj.jid.5701142 46 10.1038/sj.jid.5701142 false true Reference 62854981 /api/reference/62854981 47. Augustin M, Langenbruch AK, Gutknecht M, Radtke MA, Blome C (2012) Quality of life measures for dermatology: definition, evaluation, and interpretation. Curr Dermatol Rep. https://doi.org/10.1007/s13671-012-0020-z, DOI: 10.1007/s13671-012-0020-z 47 10.1007/s13671-012-0020-z false true Reference 62854982 /api/reference/62854982 48. Poór AK, Brodszky V, Péntek M, Gulácsi L, Ruzsa G, Hidvégi B, Holló P, Kárpáti S, Sárdy M, Rencz F (2018) Is the DLQI appropriate for medical decision-making in psoriasis patients? Arch Dermatol Res. https://doi.org/10.1007/s00403-017-1794-4, DOI: 10.1007/s00403-017-1794-4 48 10.1007/s00403-017-1794-4 false true Reference 62854983 /api/reference/62854983 49. Rencz F, Holló P, Kárpáti S, Péntek M, Remenyik É, Szegedi A, Balogh O, Herédi E, Herszényi K, Jókai H, Brodszky V, Gulácsi L (2015) Moderate to severe psoriasis patients’ subjective future expectations regarding health-related quality of life and longevity. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.12884, DOI: 10.1111/jdv.12884 49 10.1111/jdv.12884 false true Reference 62854984 /api/reference/62854984 50. Brodszky V, Tamási B, Hajdu K, Péntek M, Szegedi A, Sárdy M, Bata-Csörgő Z, Kinyó Á, Gulácsi L, Rencz F (2021) Disease burden of patients with pemphigus from a societal perspective. Expert Rev Pharmacoecon Outcomes Res. https://doi.org/10.1080/14737167.2020.1722104, DOI: 10.1080/14737167.2020.1722104 50 10.1080/14737167.2020.1722104 false true Reference 62854985 /api/reference/62854985 51. Tamási B, Brodszky V, Péntek M, Gulácsi L, Hajdu K, Sárdy M, Szegedi A, Bata-Csörgő Z, Kinyó Á, Rencz F (2019) Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. https://doi.org/10.1111/bjd.16883, DOI: 10.1111/bjd.16883 51 10.1111/bjd.16883 false true Reference 62854986 /api/reference/62854986 52. Hajdu K, Brodszky V, Stalmeier PFM, Ruzsa G, Tamási B, Gulácsi L, Péntek M, Sárdy M, Bata-Csörgő Z, Kinyó Á, Szegedi A, Rencz F (2019) Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.15765, DOI: 10.1111/jdv.15765 52 10.1111/jdv.15765 false true Reference 62854987 /api/reference/62854987 53. Mitev A, Rencz F, Tamási B, Hajdu K, Péntek M, Gulácsi L, Szegedi A, Bata-Csörgő Z, Kinyó Á, Sárdy M, Brodszky V (2019) Subjective well-being in patients with pemphigus: a path analysis. Eur J Health Econ. https://doi.org/10.1007/s10198-019-01067-w, DOI: 10.1007/s10198-019-01067-w 53 10.1007/s10198-019-01067-w false true Reference 62854988 /api/reference/62854988 54. Rencz F, Poór AK, Péntek M, Holló P, Kárpáti S, Gulácsi L, Szegedi A, Remenyik É, Hidvégi B, Herszényi K, Jókai H, Beretzky Z, Brodszky V (2018) A detailed analysis of ‘not relevant’ responses on the DLQI in psoriasis: potential biases in treatment decisions. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.14676, DOI: 10.1111/jdv.14676 54 10.1111/jdv.14676 false true Reference 62854989 /api/reference/62854989 55. Poór AK, Rencz F, Brodszky V, Gulácsi L, Beretzky Z, Hidvégi B, Holló P, Kárpáti S, Péntek M (2017) Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual Life Res. https://doi.org/10.1007/s11136-017-1699-x, DOI: 10.1007/s11136-017-1699-x 55 10.1007/s11136-017-1699-x false true Reference 62854990 /api/reference/62854990 56. Koszorú K, Hajdu K, Brodszky V, Bató A, Gergely LH, Kovács A, Beretzky Z, Sárdy M, Szegedi A, Rencz F (2022) Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis. Eur J Health Econ. https://doi.org/10.1007/s10198-022-01460-y, DOI: 10.1007/s10198-022-01460-y 56 10.1007/s10198-022-01460-y false true Reference 62854991 /api/reference/62854991 57. Koszorú K, Hajdu K, Brodszky V, Szabó Á, Borza J, Bodai K, Pónyai G, Szegedi A, Sárdy M, Rencz F (2022) General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 pandemic. Dermatitis. https://doi.org/10.1097/der.0000000000000908, DOI: 10.1097/der.0000000000000908 57 10.1097/der.0000000000000908 false true Reference 62854992 /api/reference/62854992 58. Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA (2013) Time trade-off: one methodology, different methods. Eur J Health Econ. https://doi.org/10.1007/s10198-013-0508-x, DOI: 10.1007/s10198-013-0508-x 58 10.1007/s10198-013-0508-x false true Reference 62854993 /api/reference/62854993 59. Torrance GW (1986) Measurement of health state utilities for economic appraisal: a review. J Health Econ. https://doi.org/10.1016/0167-6296(86)90020-2, DOI: 10.1016/0167-6296(86)90020-2 59 10.1016/0167-6296(86)90020-2 false true Reference 62854994 /api/reference/62854994 60. Brooks R (1996) Group E. EuroQol: the current state of play. Health Policy. https://doi.org/10.1016/0168-8510(96)00822-6, DOI: 10.1016/0168-8510(96)00822-6 60 10.1016/0168-8510(96)00822-6 false true Reference 62854995 /api/reference/62854995 61. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. https://doi.org/10.1007/s11136-011-9903-x, DOI: 10.1007/s11136-011-9903-x 61 10.1007/s11136-011-9903-x false true Reference 62854996 /api/reference/62854996 62. Ingram JR, Hadjieconomou S, Piguet V (2016) Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process. Br J Dermatol. https://doi.org/10.1111/bjd.14475, DOI: 10.1111/bjd.14475 62 10.1111/bjd.14475 false true Reference 62854997 /api/reference/62854997 63. Xiao Y, Huang X, Jing D, Huang Y, Zhang X, Shu Z, Huang Z, Su J, Li J, Zhang J, Chen M, Chen X, Shen M (2018) Assessment of the dermatology life quality index (DLQI) in a homogeneous population under lifetime arsenic exposure. Qual Life Res. https://doi.org/10.1007/s11136-018-1969-2, DOI: 10.1007/s11136-018-1969-2 63 10.1007/s11136-018-1969-2 false true Reference 62854998 /api/reference/62854998 64. Bali G, Kárpáti S, Sárdy M, Brodszky V, Hidvégi B, Rencz F (2018) Association between quality of life and clinical characteristics in patients with morphea. Qual Life Res. https://doi.org/10.1007/s11136-018-1897-1, DOI: 10.1007/s11136-018-1897-1 64 10.1007/s11136-018-1897-1 false true Reference 62854999 /api/reference/62854999 65. Finlay AY, Khan G (1994) Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x, DOI: 10.1111/j.1365-2230.1994.tb01167.x 65 10.1111/j.1365-2230.1994.tb01167.x false true Reference 62855000 /api/reference/62855000 66. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY (2005) Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol. https://doi.org/10.1111/j.0022-202X.2005.23621.x, DOI: 10.1111/j.0022-202X.2005.23621.x 66 10.1111/j.0022-202X.2005.23621.x false true Reference 62855001 /api/reference/62855001 67. Bland JM, Altman D (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. https://doi.org/10.1016/S0140-6736(86)90837-8, DOI: 10.1016/S0140-6736(86)90837-8 67 10.1016/S0140-6736(86)90837-8 false true Reference 62855002 /api/reference/62855002 68. Nikl A, Janssen MF, Brodszky V, Rencz F (2023) A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-023-02096-z, DOI: 10.1186/s12955-023-02096-z 68 10.1186/s12955-023-02096-z false true Reference 62855003 /api/reference/62855003 69. Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. https://doi.org/10.1016/j.jcm.2016.02.012, DOI: 10.1016/j.jcm.2016.02.012 69 10.1016/j.jcm.2016.02.012 false true Reference 62855004 /api/reference/62855004 70. Nguyen SH, Nguyen LH, Vu GT, Nguyen CT, Le THT, Tran BX, Latkin CA, Ho CSH, Ho RCM (2019) Health-related quality of life impairment among patients with different skin diseases in Vietnam: a cross-sectional study. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph16030305, DOI: 10.3390/ijerph16030305 70 10.3390/ijerph16030305 false true Reference 62855005 /api/reference/62855005 71. Alinia C, Yaghmaei S, Abdullah FZ, Ahmadi A, Samadi N, Pourteimour S, Safari H, Mahmoodi H, Moradi G, Piroozi B (2021) The health-related quality of life in Iranian patients with COVID-19. BMC Infect Dis. https://doi.org/10.1186/s12879-021-06170-z, DOI: 10.1186/s12879-021-06170-z 71 10.1186/s12879-021-06170-z false true Reference 62855006 /api/reference/62855006 72. Zhang Y, Zhou Z, Gao J, Wang D, Zhang Q, Zhou Z, Su M, Li D (2016) Health-related quality of life and its influencing factors for patients with hypertension: evidence from the urban and rural areas of Shaanxi Province, China. BMC Health Serv Res. https://doi.org/10.1186/s12913-016-1536-x, DOI: 10.1186/s12913-016-1536-x 72 10.1186/s12913-016-1536-x false true Reference 62855007 /api/reference/62855007 73. Huang W, Yang J, Liu Y, Liu C, Zhang X, Fu W, Shi L, Liu G (2018) Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China. BMJ Open. https://doi.org/10.1136/bmjopen-2018-022711, DOI: 10.1136/bmjopen-2018-022711 73 10.1136/bmjopen-2018-022711 false true Reference 62855008 /api/reference/62855008 74. Xu RH, Lu M, Zhang S, Dong D (2022) EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy. Eur J Health Econ. https://doi.org/10.1007/s10198-022-01551-w, DOI: 10.1007/s10198-022-01551-w 74 10.1007/s10198-022-01551-w false true Reference 62855009 /api/reference/62855009 75. Wich LG, Ma MW, Price LS, Sidash S, Berman RS, Pavlick AC, Miller G, Sarpel U, Goldberg JD, Osman I (2011) Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. J Community Health. https://doi.org/10.1007/s10900-010-9328-4, DOI: 10.1007/s10900-010-9328-4 75 10.1007/s10900-010-9328-4 false true Reference 62855010 /api/reference/62855010 76. Sayah FA, Bansback N, Bryan S, Ohinmaa A, Poissant L, Pullenayegum E, Xie F, Johnson JA (2016) Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Qual Life Res. https://doi.org/10.1007/s11136-015-1203-4, DOI: 10.1007/s11136-015-1203-4 76 10.1007/s11136-015-1203-4 false true Reference 62855011 /api/reference/62855011 77. Su J, Liu T, Li S, Zhao Y, Kuang Y (2020) A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index. J Med Econ. https://doi.org/10.1080/13696998.2020.1748636, DOI: 10.1080/13696998.2020.1748636 77 10.1080/13696998.2020.1748636 false true Reference 62855012 /api/reference/62855012 78. Hsieh B-J, Shen D, Hsu C-J, Chan TC, Cho Y-T, Tang C-H, Chu C-Y (2022) The impact of atopic dermatitis on health-related quality of life in Taiwan. J Formos Med Assoc. https://doi.org/10.1016/j.jfma.2021.03.024, DOI: 10.1016/j.jfma.2021.03.024 78 10.1016/j.jfma.2021.03.024 false true Reference 62855013 /api/reference/62855013 79. Lundin S, Bergström A, Wahlgren CF, Johansson EK, Andersson N, Ballardini N, Jonsson M, Melén E, Kull I (2022) Living with atopic dermatitis as a young adult in relation to health-related quality of life and healthcare contacts: a population-based study. Acta Derm Venereol. https://doi.org/10.2340/actadv.v102.294, DOI: 10.2340/actadv.v102.294 79 10.2340/actadv.v102.294 false true Reference 62855014 /api/reference/62855014 80. Andersen YM, Zachariae C, Thomsen SF, Thyssen JP, Egeberg A (2024) Estimating the burden of skin diseases using patient-reported daily time trade-off as a measure of disease impact and unmet needs. JEADV Clin Pract. https://doi.org/10.1002/jvc2.305, DOI: 10.1002/jvc2.305 80 10.1002/jvc2.305 false true Reference 62855015 /api/reference/62855015 81. Schneider PP, van Hout B, Heisen M, Brazier J, Devlin N (2022) The online elicitation of personal utility functions (OPUF) tool: a new method for valuing health states. Wellcome Open Res. https://doi.org/10.12688/wellcomeopenres.17518.1, DOI: 10.12688/wellcomeopenres.17518.1 81 10.12688/wellcomeopenres.17518.1 false true Reference 62855016 /api/reference/62855016 82. Richardson J, Chen G, Khan MA, Iezzi A (2015) Can multi-attribute utility instruments adequately account for subjective well-being? Med Decis Making. https://doi.org/10.1177/0272989x14567354, DOI: 10.1177/0272989x14567354 82 10.1177/0272989x14567354 false true Reference 62855017 /api/reference/62855017 83. Boye KS, Matza LS, Feeny DH, Johnston JA, Bowman L, Jordan JB (2014) Challenges to time trade-off utility assessment methods: when should you consider alternative approaches? Expert Rev Pharmacoecon Outcomes Res. https://doi.org/10.1586/14737167.2014.912562, DOI: 10.1586/14737167.2014.912562 83 10.1586/14737167.2014.912562 false true Reference 62855018 /api/reference/62855018 84. Feng YS, Jiang R, Pickard AS, Kohlmann T (2022) Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset. Qual Life Res. https://doi.org/10.1007/s11136-021-02922-1, DOI: 10.1007/s11136-021-02922-1 84 10.1007/s11136-021-02922-1 false true Reference 62855019 /api/reference/62855019 85. Meregaglia M, Tarricone R (2022) Feasibility of deriving health state utilities in mycosis fungoides cutaneous T-cell lymphoma using mapping algorithms. PharmacoEconomics - Open. https://doi.org/10.1007/s41669-022-00326-6, DOI: 10.1007/s41669-022-00326-6 85 10.1007/s41669-022-00326-6 false true Reference 62855020 /api/reference/62855020 86. Salmani H, Nasiri S, Alemrajabi M, Ahmadi M (2024) Advancing patient-centered cancer care: a systematic review of electronic patient-reported outcome measures. Front Rehabil Sci. https://doi.org/10.3389/fresc.2024.1427712, DOI: 10.3389/fresc.2024.1427712 86 10.3389/fresc.2024.1427712 false true Reference 62855021 /api/reference/62855021 87. Barbieri JS, Gelfand JM (2019) Influence of “not relevant” responses on the dermatology life quality index (DLQI) for patients with psoriasis in the United States. JAMA Dermatol. https://doi.org/10.1001/jamadermatol.2018.5655, DOI: 10.1001/jamadermatol.2018.5655 87 10.1001/jamadermatol.2018.5655 false true Reference 62855022 /api/reference/62855022 88. Langenbruch A, Radtke MA, Gutknecht M, Augustin M (2019) Does the dermatology life quality index (DLQI) underestimate the disease-specific burden of psoriasis patients? J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.15226, DOI: 10.1111/jdv.15226 88 10.1111/jdv.15226 false true Reference 62855023 /api/reference/62855023 89. Arnold D, Girling A, Stevens A, Lilford R (2009) Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. BMJ. https://doi.org/10.1136/bmj.b2688, DOI: 10.1136/bmj.b2688 89 10.1136/bmj.b2688 false true Reference 62855024 /api/reference/62855024 90. Foster E, Chen Z, Ofori-Asenso R, Norman R, Carney P, O’Brien TJ, Kwan P, Liew D, Ademi Z (2019) Comparisons of direct and indirect utilities in adult epilepsy populations: a systematic review. Epilepsia. https://doi.org/10.1111/epi.16396, DOI: 10.1111/epi.16396 90 10.1111/epi.16396 false true /api/publication/35733167 Balázs Péter György et al. Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis. (2025) ARCHIVES OF DERMATOLOGICAL RESEARCH 0340-3696 1432-069X 317 1<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10070945"><a href="/gui2/?type=authors&mode=browse&sel=10070945" target="_blank">Balázs Péter György ✉ (<span class="authorship-author-name">Balázs Péter György</span> <span class="authorAux-mtmt"> Egészség-gazdaságtan</span>) </a> </span> <span class="author-affil"><span title="Budapesti Corvinus Egyetem">BCE</span>/<span title="Társadalom- és Politikatudományi Intézet">TPTI</span>/Egészségpolitika Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10043775"><a href="/gui2/?type=authors&mode=browse&sel=10043775" target="_blank">Gáspár Krisztián (<span class="authorship-author-name">Gáspár Krisztián</span> <span class="authorAux-mtmt"> Bőrgyógyászat, allergológia, immunológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Bőrgyógyászati Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10069064"><a href="/gui2/?type=authors&mode=browse&sel=10069064" target="_blank">Gergely Hunor L. (<span class="authorship-author-name">Gergely László Hunor</span> <span class="authorAux-mtmt"> Bőr- és nemi betegségek</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hajdú Krisztina </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10019467"><a href="/gui2/?type=authors&mode=browse&sel=10019467" target="_blank">Holló Péter (<span class="authorship-author-name">Holló Péter</span> <span class="authorAux-mtmt"> Bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10070359"><a href="/gui2/?type=authors&mode=browse&sel=10070359" target="_blank">Koszorú Kamilla (<span class="authorship-author-name">Koszorú Kamilla</span> <span class="authorAux-mtmt"> Bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10037620"><a href="/gui2/?type=authors&mode=browse&sel=10037620" target="_blank">Poór Adrienn Katalin (<span class="authorship-author-name">Poór Adrienn Katalin</span> <span class="authorAux-mtmt"> bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10015457"><a href="/gui2/?type=authors&mode=browse&sel=10015457" target="_blank">Sárdy Miklós (<span class="authorship-author-name">Sárdy Miklós</span> <span class="authorAux-mtmt"> Bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010393"><a href="/gui2/?type=authors&mode=browse&sel=10010393" target="_blank">Szegedi Andrea (<span class="authorship-author-name">Szegedi Andrea</span> <span class="authorAux-mtmt"> Dermatológia - immunológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Bőrgyógyászati Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10037581"><a href="/gui2/?type=authors&mode=browse&sel=10037581" target="_blank">Tamási Béla (<span class="authorship-author-name">Tamási Béla</span> <span class="authorAux-mtmt"> bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10002438"><a href="/gui2/?type=authors&mode=browse&sel=10002438" target="_blank">Wikonkál Norbert (<span class="authorship-author-name">Wikonkál Norbert</span> <span class="authorAux-mtmt"> Bőrgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Bőr-, Nemikórtani és Bőronkológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10020545"><a href="/gui2/?type=authors&mode=browse&sel=10020545" target="_blank">Brodszky Valentin (<span class="authorship-author-name">Brodszky Valentin</span> <span class="authorAux-mtmt"> health outcome research</span>) </a> </span> <span class="author-affil"><span title="Budapesti Corvinus Egyetem">BCE</span>/<span title="Társadalom- és Politikatudományi Intézet">TPTI</span>/Egészségpolitika Tanszék</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35733167" target="_blank">Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis</a></div> <div> <span class="journal-title">ARCHIVES OF DERMATOLOGICAL RESEARCH</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0340-3696">0340-3696</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1432-069X">1432-069X</a>)</span>: <span class="journal-volume">317</span> <span class="journal-issue">1</span> <span class="page"> Paper 291. 14 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1007/s00403-024-03786-4" target="_blank" href="https://doi.org/10.1007/s00403-024-03786-4"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001400510600008" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001400510600008"> WoS </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:blue" title="10885" target="_blank" href="http://unipub.lib.uni-corvinus.hu/10885"> CorvinusKutatasok </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85216254902" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85216254902"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39825944" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39825944&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Dermatology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;35733167&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 19 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35733167</span> | <span class="status-data status-ADMIN_APPROVED"> Admin láttamozott </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2026.06.02. 11:09 Boros Annamária (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2026.06.05. 15:23 Boros Annamária (MTMT Központi admin) </div> </div></div>